Filariasis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:


===Prevalence===
===Prevalence===
*Lymphatic filariasis affects over 120 million people and it has been the leading causes of disability among filariasis patients.  
*Lymphatic filariasis affects over 120 million people and it has been the leading causes of disability among filariasis patients.<ref name="pmid25243263">{{cite journal| author=| title=Global programme to eliminate lymphatic filariasis: progress report, 2013. | journal=Wkly Epidemiol Rec | year= 2014 | volume= 89 | issue= 38 | pages= 409-18 | pmid=25243263 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25243263  }} </ref>
*Filariasis causes disability in 40 million of the patients.<ref name="pmid21887884">{{cite journal| author=| title=Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010. | journal=Wkly Epidemiol Rec | year= 2011 | volume= 86 | issue= 35 | pages= 377-88 | pmid=21887884 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21887884  }} </ref>
*The prevelance of bancrofti filariasis (filariasis caused by W. Bancrofti) is 90,000 per 100,000 individual.  
*The prevelance of bancrofti filariasis (filariasis caused by W. Bancrofti) is 90,000 per 100,000 individual.  



Revision as of 14:44, 29 June 2017

Filariasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Filariasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Filariasis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Filariasis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Filariasis epidemiology and demographics

on Filariasis epidemiology and demographics

Filariasis epidemiology and demographics in the news

Blogs on Filariasis epidemiology and demographics

Directions to Hospitals Treating Filariasis

Risk calculators and risk factors for Filariasis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Epidemiology and Demographics

Prevalence

  • Lymphatic filariasis affects over 120 million people and it has been the leading causes of disability among filariasis patients.[1]
  • Filariasis causes disability in 40 million of the patients.[2]
  • The prevelance of bancrofti filariasis (filariasis caused by W. Bancrofti) is 90,000 per 100,000 individual.

In the United States, Charleston, South Carolina, was the last known place with lymphatic filariasis. The infection disappeared early in the 20th century. Currently, you can not get infected in the U.S.

Geographic Distribution

Among the agents of lymphatic filariasis, Wuchereria bancrofti is encountered in tropical areas worldwide; Brugia malayi is limited to Asia; and Brugia timori is restricted to some islands of Indonesia. The agent of river blindness, Onchocerca volvulus, occurs mainly in Africa, with additional foci in Latin America and the Middle East. Among the other species, Loa loa and Mansonella streptocerca are found in Africa; Mansonella perstans occurs in both Africa and South America; and Mansonella ozzardi occurs only ins the Americas, from Mexico south to South America and in the Caribbean. In endemic areas of the world (e.g., Malaipea in Indonesia), up to 54% of the population may have microfilariae in their blood.[3] In the Americas, only four countries are currently known to be endemic: Haiti, the Dominican Republic, Guyana and Brazil.

References

  1. "Global programme to eliminate lymphatic filariasis: progress report, 2013". Wkly Epidemiol Rec. 89 (38): 409–18. 2014. PMID 25243263.
  2. "Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010". Wkly Epidemiol Rec. 86 (35): 377–88. 2011. PMID 21887884.
  3. Aupali T, Ismid IS, Wibowo H; et al. (2006). "Estimation of the prevalence of lymphatic filariasis by a pool screen PCR assay using blood spots collected on filter paper". Tran R Soc Trop Med Hyg. 100 (8): 753&ndash, 9.


Template:WikiDoc Sources